Table 4. Survey responses regarding stroke risk assessment in critically ill patients with new-onset atrial fibrillation.
| Please tick all answers that reflect your views on stroke risk assessment in critically ill patients with new-onset atrial fibrillation: | Bar | Response | % |
|---|---|---|---|
| I do not use stroke risk scores routinely in critically ill patients with new onset AF to assess the need for anti-coagulation |
|
246 | 67.96% |
| I regularly calculate a risk score (e.g., CHAD2, CHA2DS2-VASc) to assess the need for anti-coagulation |
|
39 | 10.77% |
| Stroke risk scores inaccurately reflect the risk of embolic events in critically ill patients with new-onset atrial fibrillation due to prothrombotic changes associated with critical illness |
|
112 | 30.94% |
| Stroke risk scores favour anti-coagulation despite a higher risk of bleeding in critical illness |
|
73 | 20.17% |
| Modified risk scores should be developed for critically ill patients with new-onset atrial fibrillation |
|
170 | 46.96% |
| Total | 640 | 100.00% |